CLDX logo

Celldex Therapeutics (CLDX) Company Overview

Profile

Full Name:

Celldex Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 15, 1986

Indexes:

Not included

Description:

Celldex Therapeutics (CLDX) is a biotechnology company focused on developing innovative therapies for cancer and other serious diseases. They specialize in immunotherapy, using the body’s immune system to fight tumors, and are working on advanced treatments to improve patient outcomes.

Events Calendar

Earnings

Next earnings date:

May 6, 2025

Recent quarterly earnings:

Oct 28, 2024

Recent annual earnings:

Feb 26, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 11, 2019

Analyst ratings

Recent major analysts updates

Mar 3, 25 HC Wainwright & Co.
Buy
Mar 3, 25 Goldman Sachs
Neutral
Feb 28, 25 HC Wainwright & Co.
Buy
Feb 13, 25 UBS
Buy
Jan 2, 25 Cantor Fitzgerald
Overweight
Dec 20, 24 HC Wainwright & Co.
Buy
Dec 19, 24 HC Wainwright & Co.
Buy
Nov 20, 24 HC Wainwright & Co.
Buy
Nov 7, 24 HC Wainwright & Co.
Buy
Oct 28, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Celldex Therapeutics?
  • Does Celldex Therapeutics pay dividends?
  • What sector is Celldex Therapeutics in?
  • What industry is Celldex Therapeutics in?
  • What country is Celldex Therapeutics based in?
  • When did Celldex Therapeutics go public?
  • Is Celldex Therapeutics in the S&P 500?
  • Is Celldex Therapeutics in the NASDAQ 100?
  • Is Celldex Therapeutics in the Dow Jones?
  • When was Celldex Therapeutics's last earnings report?
  • When does Celldex Therapeutics report earnings?
  • Should I buy Celldex Therapeutics stock now?

What is the ticker symbol for Celldex Therapeutics?

The ticker symbol for Celldex Therapeutics is NASDAQ:CLDX

Does Celldex Therapeutics pay dividends?

No, Celldex Therapeutics does not pay dividends

What sector is Celldex Therapeutics in?

Celldex Therapeutics is in the Healthcare sector

What industry is Celldex Therapeutics in?

Celldex Therapeutics is in the Biotechnology industry

What country is Celldex Therapeutics based in?

Celldex Therapeutics is headquartered in United States

When did Celldex Therapeutics go public?

Celldex Therapeutics's initial public offering (IPO) was on May 15, 1986

Is Celldex Therapeutics in the S&P 500?

No, Celldex Therapeutics is not included in the S&P 500 index

Is Celldex Therapeutics in the NASDAQ 100?

No, Celldex Therapeutics is not included in the NASDAQ 100 index

Is Celldex Therapeutics in the Dow Jones?

No, Celldex Therapeutics is not included in the Dow Jones index

When was Celldex Therapeutics's last earnings report?

Celldex Therapeutics's most recent earnings report was on Oct 28, 2024

When does Celldex Therapeutics report earnings?

The next expected earnings date for Celldex Therapeutics is May 6, 2025

Should I buy Celldex Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions